Hendrik-Tobias Arkenau

Scientific Advisor at Engitix Therapeutics

Hendrik-Tobias Arkenau is the Executive Medical Director of the Sarah Cannon Research Institute UK (SCRI UK) and Clinical Lead for the Hospital Corporation of America International Cancer Service Line. Since founding the SCRI UK in 2010, he has built a portfolio of over 180 early-stage cancer clinical trials. He is a Fellow of the Royal College of Physicians.

Links


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Engitix Therapeutics

To create a healthier future for patients with life-threatening diseases, Engitix Therapeutics is using its pioneering human extracellular matrix (ECM)-based discovery platform to develop a portfolio of programmes in fibrosis and solid tumors.


Industries

Employees

51-200

Links